Search

everythinglearnresearchcommunity

for

Search:↓

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

Children are at risk of health issues from exposure to platinum group elements from car exhausts.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Modern wound dressings like hydrocolloids, alginates, and hydrogels improve healing and are cost-effective.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Analog 23 is a promising compound for prostate cancer treatment.

The we/we wal/wal mice have defects in hair growth and skin layer formation, causing hair loss, useful for understanding alopecia.

The mini-lift is a less invasive face-lift for younger patients that is quicker, cheaper, and has a fast recovery, but is less effective for the midface and excessive neck skin.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

Improving how drugs are absorbed through the skin could better treat mange in wombats.

Human hair follicle cells can be turned into neural stem cell-like cells, which might help treat brain diseases.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Family-based treatment is the best outpatient care for stable teens with anorexia, and more research is needed on medication and treatment effectiveness for young people with eating disorders.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Elastic Net DNA methylation clocks are inaccurate for predicting age and health status; a "noise barometer" may better indicate aging and disease.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Common cosmetic dermatology techniques improve skin damaged by the sun and aging.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Spironolactone and clascoterone are promising acne treatments with fewer side effects.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Dermatologists should customize cosmetic treatments for dark-skinned patients to minimize risks and complications.

Radiographers in private hospitals face many health issues due to heavy workloads and long hours.

Trazodone and chlorpromazine may help treat sexual dysfunction caused by finasteride and SSRIs.

A young Persian cat had a skin infection and low platelets, treated with various medications.

The new gel for psoriasis is effective, stable, and easy to apply.